Navigation Links
MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations
Date:2/27/2008

ommunity-based programs to efficiently vaccinate a large number of people.

"Our experience has been that children are generally quite accepting of a vaccine that does not involve a needle," Malinoski said. "Additionally, parents and health care providers may appreciate that FluMist works differently than the flu shot in that it uses live, attenuated -- or weakened -- vaccine viruses within the vaccine to help stimulate an immune response that closely resembles the body's natural protective response to an influenza infection. This may also explain why we have observed some protection against mismatched strains in past seasons."

While past clinical trial results are not indicative of future results, in multiple studies across several seasons FluMist demonstrated that it could help offer protection against mismatched influenza A strains(3).

-- In a two-year, multicenter, randomized, double-blind placebo-controlled

trial (conducted between 1996-1998) in children 24 months-71 months of

age, FluMist provided comparable protection in a year with matched

strains (95 percent protection -- year two) and a year with mismatched

strains (87 percent protection -- year two). The mismatched strain

that circulated during the studied season was A/Sydney (H3N2).

-- In a head-to-head study conducted during the 2004-2005 influenza season

that included over 4,000 children between two and five years of age,

when looking specifically at strains that were mismatched, there were

54.2 percent fewer cases of flu in children who received FluMist versus

those that received the flu shot (Attack rate 3.2 percent vs 7.1

percent, respectively). The mismatched strains that circulated during

the studied season were A/California-like (H3N2), B/Florida and

B/Victoria lineage strains.

MedImmune strongly supports the CDC's efforts to encourage vaccination aga
'/>"/>

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. MedImmune Expands Scientific and Engineering Leadership
2. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
3. MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV
4. MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics
5. Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results
6. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
7. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
8. Check Your Emergency Preparedness Kits When You Set Your Clocks, Says New American Public Health Association Campaign
9. TFAH Applauds Release of CDCs State-Specific Public Health Emergency Preparedness Report
10. K-State Trauma Researcher Says Being Prepared, Taking Action Are Vital in Preventing Tragedies Like the One at NIU
11. Many States Still Fall Short in Emergency Preparedness: Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... Dallas, TX (PRWEB) November 23, 2014 ... Energy Devices Market 2006 to 2020 - Asia-Pacific” ... and energy devices market segments: minimally invasive body ... resurfacing devices. The analysis includes market size data ... period for the following countries: China, Japan, South ...
(Date:11/23/2014)... Pro Ace Care, a renowned Vancouver hot ... be providing an 8 year warranty on its selected hot ... went up due to the impending winter season, it was ... the premium service that the company provides. As a result, ... John Wood and Bradford hot water tanks. , “Every ...
(Date:11/23/2014)... -- Close friends have more influence on teens, alcohol ... study says. "We,ve known for a long ... individual alcohol use, but there are no common studies ... friend group,s influence on those decisions," Jonathon Beckmeyer, an ... said in a university news release. Beckmeyer analyzed ...
(Date:11/23/2014)... November 23, 2014 Locks-Magnetic.com, a notable ... doors. Moreover, all the new products are available at ... marketing manager is proud of the new emergency doors. ... automatically. And customers can choose from several colors. All ... high quality emergency door release is not as easy ...
(Date:11/23/2014)... To show thanks to new and old ... white evening dresses for weddings. Customers who need ... iFitDress.com is a distinguished dress manufacturer, and it is among ... customers for a very long time. The CEO of this ... will be able to buy not only a beautiful dress, ...
Breaking Medicine News(10 mins):Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Close Friends May Be Key to Teens' Drinking 2Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2
... patients is in early period , , TUESDAY, Feb. 5 (HealthDay ... after heart patients stop taking the clot-preventing drug Plavix are ... make this observation," said Dr. P. Michael Ho, a cardiologist ... a report in the Feb. 6 issue of the ...
... ,PLAY SAFE IN THE SUN, ... ... a,subsidiary of the L,Oreal Group, announced that they have granted the,Women,s Dermatologic ... Safe in the Sun campaign, effective April,2008. The WDS educational outreach campaign ...
... William F. Balistreri, MD, Editor of The Journal of ... the Study of Liver Diseases (AASLD) 2007 Distinguished Service ... AASLD as well as to the liver disease community. ... award. , The AASLD was privileged to honor Dr. ...
... of the sardine fishery off California for decades has ... large fluctuations in the sardine population. Before its collapse, ... and formed the setting of John Steinbecks Cannery Row ... Oceanography at UC San Diego have now shed light ...
... Magazine,s list ranks 33, COLUMBUS, Ga., Feb. ... education and leadership programs helped Aflac leap to,Number ... for,employees according to Training Magazine,s annual Top 125 ... Georgia World Congress Center, the,insurer was honored for ...
... NewYork-Presbyterian Hospital/Weill Cornell Medical Center has created an ... and treatment of the disease. The new Cancer ... Andrew Dannenberg. , A joint initiative of Weill ... will create strengthened and expanded research programs and ...
Cached Medicine News:Health News:First 90 Days After Stopping Plavix Most Dangerous 2Health News:L'Oreal USA Announces Three-Year Support of Women's Dermatologic Society Foundation Community Outreach 2Health News:L'Oreal USA Announces Three-Year Support of Women's Dermatologic Society Foundation Community Outreach 3Health News:William F. Balistreri, M.D., honored with Distinguished Service Award by AASLD 2Health News:Scripps scientists peg wind as the force behind fish booms and busts 2Health News:Scripps scientists peg wind as the force behind fish booms and busts 3Health News:Training Magazine Applauds Aflac's Employee Learning Programs 2Health News:Training Magazine Applauds Aflac's Employee Learning Programs 3Health News:NewYork-Presbyterian/Weill Cornell creates world-class cancer center 2
(Date:11/21/2014)... , Nov. 21, 2014   Rock Creek ... that the Company is scheduled to present at the ... Francisco, CA on January 12-14, 2015. ... and CEO of Rock Creek Pharmaceuticals, will present preclinical ... cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. Dr. Mullan ...
(Date:11/21/2014)... November 2014 Clementia ... gegeben, dass die Europäische Arzneimittel-Agentur (European ... als Orphan-Medizinprodukt an Palovarotene vergeben hat, ... Behandlung von Fibrodysplasia ossificans progressiva (FOP). ... genetische Krankheit, die von schmerzhaften, wiederkehrenden ...
(Date:11/21/2014)... 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ) announced ... will be presenting at the 26 th Annual Piper ... New York . The formal presentation is ... In addition, Mr. Krakauer and Jorgen B. Hansen , ... during the day. An audio webcast will ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3
... BioTrends Research Group, Inc. announces the release of the ... and Cimzia report. The survey was completed by ... qualitative interviews with a subset (n=20) of the survey respondents to ... employed to differentiate the products. Over the course of the ...
... , ATLANTA, Dec. 23 Alimera Sciences, Inc., a privately ... commercialization of prescription ophthalmic pharmaceuticals, today reported top-line results from ... The FAME Study consists of two Phase 3 pivotal clinical ... Iluvien in the treatment of diabetic macular edema (DME). The ...
Cached Medicine Technology:Cimzia Draws Even With Simponi at Six Months Post Launch According to Recent BioTrends Survey 2Cimzia Draws Even With Simponi at Six Months Post Launch According to Recent BioTrends Survey 3Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema 2Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema 3Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema 4Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema 5Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema 6
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: